Phosphodiesterase type 5 inhibition attenuates cyclosporine A induced nephrotoxicity in mice

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Biotechnic & Histochemistry

• Publication date

  2015-03-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3109/10520295.2014.976270PMID 25420893
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sildenafil promotes smooth muscle preservation and ameliorates fibrosis through modulation of extracellular matrix and tissue growth factor gene expression after bilateral cavernosal nerve resection in the rat.

  2011cited by this paper
• Early short-term imatinib treatment is sufficient to prevent the development of chronic allograft nephropathy.

  2011cited by this paper
• The Phosphodiesterase-5 Inhibitor Vardenafil Is a Potent Inhibitor of ABCB1/P-Glycoprotein Transporter

  2011cited by this paper
• Effects of a cGMP-specific phosphodiesterase inhibitor on expression of endothelial nitric oxide synthase and vascular endothelial growth factor in rats with cyclosporine-induced nephrotoxicity.

  2010cited by this paper
• Modulation of inflammatory response by selective inhibition of cyclooxygenase-1 and cyclooxygenase-2 in acute kidney injury

  2010cited by this paper
• Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis

  2008cited by this paper
• Role of prostaglandins in collecting duct-derived endothelin-1 regulation of blood pressure and water excretion.

  2007cited by this paper
• Selective COX-2 inhibition markedly slows disease progression and attenuates altered prostanoid production in Han:SPRD-cy rats with inherited kidney disease.

  2007cited by this paper
• Activation of Intrarenal Complement System in Mouse Model for Chronic Cyclosporine Nephrotoxicity

  2007cited by this paper
• Cyclic Nucleotide Phosphodiesterase (PDE) Inhibitors: Novel Therapeutic Agents for Progressive Renal Disease

  2007cited by this paper
• Developmental regulation of calcineurin isoforms in the rodent kidney: association with COX-2.

  2007cited by this paper
• Calcineurin Inhibitor–Induced Nephrotoxicity and Renal Expression of P‐glycoprotein

  2005cited by this paper
• Inhibitory Effect of Pravastatin on Transforming Growth Factor β1-Inducible Gene h3 Expression in a Rat Model of Chronic Cyclosporine Nephropathy

  2005cited by this paper
• Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development

  2005cited by this paper
• Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors.

  2005cited by this paper
• Cyclooxygenase 1 and/or 2 blockade ameliorates the renal tissue damage triggered by ischemia and reperfusion injury.

  2005cited by this paper
• Phosphodiesterase type 5 inhibition ameliorates nephrotoxicity induced by cyclosporin A in spontaneous hypertensive rats.

  2003cited by this paper
• Cyclosporine A suppresses cyclooxygenase-2 expression in the rat kidney.

  2002cited by this paper
• The effect of acute rejection and cyclosporin A—treatment on induction of platelet-derived growth factor and its receptors during the development of chronic rat renal allograft rejection1

  2002cited by this paper
• Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells.

  2002cited by this paper
• Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.

  2001influential reference
• Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies

  2001cited by this paper
• Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes.

  2001cited by this paper
• Nitric oxide regulates renal cortical cyclooxygenase-2 expression.

  2000cited by this paper
• Potentiation by nitric oxide of cyclosporin A and FK506-induced apoptosis in renal proximal tubule cells.

  2000cited by this paper
• Renal effects of selective cyclooxygenase‐2 inhibition in normotensive salt‐depleted subjects

  1999cited by this paper
• Cyclosporin exerts a direct fibrogenic effect on human tubulointerstitial cells: roles of insulin-like growth factor I, transforming growth factor beta1, and platelet-derived growth factor.

  1999cited by this paper
• In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine.

  1998cited by this paper
• In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine.

  1998cited by this paper
• Role of P-glycoprotein in chronic cyclosporine nephrotoxicity and its relationship to intrarenal angiotensin II deposits.

  1998cited by this paper
• Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506.

  1996cited by this paper
• Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy.

  1996cited by this paper
• Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy.

  1996cited by this paper
• Misoprostol Partially Inhibits the Renal Scarring of Chronic Cyclosporine Nephrotoxicity.

  1995cited by this paper
• Role of platelet-derived growth factor in renal injury.

  1995cited by this paper
• CYCLOSPORINE STIMULATES EXPRESSION OF TRANSFORMING GROWTH FACTOR-β IN RENAL CELLS POSSIBLE MECHANISM OF CYCLOSPORINES ANTIPROLIFERATIVE EFFECTS

  1995cited by this paper
• Increased platelet-derived growth factor in the kidneys of cyclosporin-treated rats.

  1994cited by this paper
• Direct demonstration of high affinity interactions of immunosuppressant drugs with the drug binding site of the human P-glycoprotein.

  1994cited by this paper
• Cellular and molecular mechanisms of cyclosporin nephrotoxicity.

  1990cited by this paper
• Kidney epithelial cells express c-sis protooncogene and secrete PDGF-like protein.

  1988cited by this paper

• Reno-protective effects of Phosphodiesterase 5 inhibitors

  2021cites this paper
• Phosphodiesterase-5 inhibitor sildenafil attenuates kidney injury induced by Bothrops alternatus snake venom.

  2021cites this paper
• Current Concepts on the Reno-Protective Effects of Phosphodiesterase 5 Inhibitors in Acute Kidney Injury: Systematic Search and Review

  2020cites this paper
• Mechanism of cyclosporine A nephrotoxicity: Oxidative stress, autophagy, and signalings.

  2018cites this paper
• Phosphodiesterase type 5 inhibitors and kidney disease

  2015cites this paper